Vinod Verma Selected Research

Neoplasm Metastasis (Metastasis)

1/2013

Probiotic metabolites as epigenetic targets in the prevention of colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod Verma Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 08/2010
3	Inflammation (Inflammations) 04/2022 - 01/2013
3	COVID-19 04/2022 - 12/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 01/2012
2	Dysbiosis 04/2022 - 12/2021
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 12/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2022
1	Hyperglycemia 04/2022
1	Diabetes Mellitus 04/2022
1	Hypertension (High Blood Pressure) 04/2022
1	Noncommunicable Diseases 01/2020
1	Obesity 01/2020
1	Teratocarcinoma 11/2019
1	Hepatolenticular Degeneration (Wilson's Disease) 11/2019
1	Arthritis (Polyarthritis) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Chronic Disease (Chronic Diseases) 10/2013
1	Hypercholesterolemia 03/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Multiple Myeloma 12/2012
1	Lymphoma (Lymphomas) 12/2012
1	Leukemia 12/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2012
1	Coronary Disease (Coronary Heart Disease) 01/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Lactose Intolerance (Intolerance, Lactose) 01/2012
1	Carcinogenesis 12/2011
1	Body Weight (Weight, Body) 12/2011

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 04/2022 - 01/2012
3	CholesterolIBA 01/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 12/2021 - 05/2013
1	Polystyrenes (Polystyrene)IBA 05/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2022
1	Angiotensin-Converting Enzyme 2IBA 04/2022
1	Angiotensin Receptor AntagonistsIBA 04/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	SteroidsIBA 12/2021
1	ZincIBA 12/2021
1	Hormones (Hormone)IBA 01/2020
1	Endocrine DisruptorsIBA 01/2020
1	cupric chloride (copper(II) chloride)FDA Link 11/2019
1	ChloridesIBA 11/2019
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 11/2019
1	CopperIBA 11/2019
1	Copper-Transporting ATPasesIBA 11/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Celecoxib (Celebrex)FDA Link 01/2014
1	CytokinesIBA 10/2013
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	NF-kappa B (NF-kB)IBA 10/2013
1	ChemokinesIBA 10/2013
1	Chemokine ReceptorsIBA 10/2013
1	AcidsIBA 01/2013
1	Bacteriocins (Lantibiotics)IBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	AflatoxinsIBA 12/2011
1	chlorophyllin (copper chlorophyll)IBA 12/2011
1	GlucuronidaseIBA 08/2010
1	MutagensIBA 08/2010
1	Bile Acids and Salts (Bile Acids)IBA 08/2010
1	beta-GlucosidaseIBA 08/2010
1	CarcinogensIBA 08/2010
1	EnzymesIBA 08/2010

Therapy/Procedure

5	Therapeutics 12/2021 - 12/2012
1	Self Medication 12/2021
1	Drug Therapy (Chemotherapy) 12/2012
1	Intraperitoneal Injections 12/2011